Open AccessMetabolic profiles of serum samples from ground glass opacity represent potential diagnostic biomarkers for lung cancer
Author(s) -
Jianzhong Li,
Yuanyang Lai,
JianYong Sun,
Lina Guan,
Hongfei Zhang,
Yang Chen,
Yuefeng Ma,
Tao Liu,
Wen Zhao,
Xiaolong Yan,
Shaomin Li
Publication year - 2019
Publication title -
translational lung cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 41
eISSN - 2226-4477
pISSN - 2218-6751
DOI - 10.21037/tlcr.2019.07.02
Subject(s) - lung cancer , medicine , glutamine , ground glass opacity , cancer , biomarker , gastroenterology , pathology , oncology , adenocarcinoma , biochemistry , chemistry , amino acid
Lung cancer is a leading cause of cancer deaths worldwide. Low-dose computed tomography (LDCT) screening trials indicated that LDCT is effective for the early detection of lung cancer, but the findings were accompanied by high false positive rates. Therefore, the detection of lung cancer needs complementary blood biomarker tests to reduce false positive rates.